[Etiologic analysis of severe neonatal upper respiratory tract obstruction]

Li-ping Wang1, Ming Zhang, Wei Li

  • 1Department of Otorhinolaryngology, Shengjing Hospital, China Medical University, Shenyang 110004, China. wanglp@cmu2h.com

Insights

Congenital diseases cause most severe upper respiratory obstruction in newborns. Prompt diagnosis and treatment of these congenital conditions are crucial for improving outcomes and survival rates.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Otolaryngology

Context:

  • Severe upper respiratory tract obstruction presents a critical challenge in neonates.
  • Accurate diagnosis is essential for effective management and improved patient outcomes.

Purpose:

  • This study investigates the primary causes of severe upper respiratory obstruction in neonates.
  • The objective is to identify congenital anomalies contributing to neonatal respiratory distress.

Summary:

  • A retrospective analysis of 47 neonates with severe dyspnea revealed that congenital diseases accounted for 87.2% of cases.
  • Congenital laryngeal stridor and upper respiratory tract cysts were the most frequent diagnoses, with significant rates of misdiagnosis.
  • Other causes included laryngotracheobronchitis, respiratory tract stenosis, laryngeal webs, vocal cord paralysis, and genetic syndromes.

Impact:

  • Findings underscore the critical role of congenital abnormalities in neonatal respiratory obstruction.
  • Highlights the importance of early and accurate diagnosis for timely intervention and better prognosis.
  • Emphasizes the need for specialized diagnostic approaches to differentiate various congenital causes and guide treatment strategies.
Abstract

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...